Cited by 1,515Histone Deacetylase Inhibitors ResearchGenomics and Chromatin DynamicsEpigenetics and DNA Methylation

Inhibition of Histone Deacetylase Activity by Butyrate

Open access
Davie, James R.·2003·The Journal of Nutrition

Abstract

This article reviews the effects of the short-chain fatty acid butyrate on histone deacetylase (HDAC) activity. Sodium butyrate has multiple effects on cultured mammalian cells that include inhibition of proliferation, induction of differentiation and induction or repression of gene expression. The observation that butyrate treatment of cells results in histone hyperacetylation initiated a flurry of activity that led to the discovery that butyrate inhibits HDAC activity. Butyrate has been an essential agent for determining the role of histone acetylation in chromatin structure and function. Interestingly, inhibition of HDAC activity affects the expression of only 2% of mammalian genes. Promoters of butyrate-responsive genes have butyrate response elements, and the action of butyrate is often mediated through Sp1/Sp3 binding sites (e.g., p21(Waf1/Cip1)). We demonstrated that Sp1 and Sp3 recruit HDAC1 and HDAC2, with the latter being phosphorylated by protein kinase CK2. A model is proposed in which inhibition of Sp1/Sp3-associated HDAC activity leads to histone hyperacetylation and transcriptional activation of the p21(Waf1/Cip1) gene; p21(Waf1/Cip1) inhibits cyclin-dependent kinase 2 activity and thereby arrests cell cycling. Pending the cell background, the nonproliferating cells may enter differentiation or apoptotic pathways. The potential of butyrate and HDAC inhibitors in the prevention and treatment of cancer is presented.

Integrity signals

Registry

Crossref · 10.1093/jn/133.7.2485s

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • All SCFAs induce histone deacetylase (HDAC) inhibitory effects, with butyrate being the most potent inhibitor of class I and IIa HDACs.

    “All SCFAs induce histone deacetylase (HDAC) inhibitory effects, with butyrate being the most potent inhibitor of class I and IIa HDACs”

    From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Davie, 2003

  • Butyrate is the most potent HDAC inhibitor among SCFAs and generally inhibits class I HDACs (HDAC1, -2, -3, and -8) and class IIa HDACs (HDAC4, -5, -7, and -9), but not class IIb HDACs (HDAC6 and HDAC10) and class III HDACs (sirtuins).

    “Among the SCFAs, butyrate is the most potent HDAC inhibitor that is generally thought to inhibit the activity of class I HDACs (HDAC1, −2, −3, and −8) and class IIa HDACs (HDAC4, −5, −7, and −9), but not class IIb HDACs (HDAC6 and HDAC10) and class III HDACs (sirtuins).288”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Davie, J. R.
Affiliations
University of Manitoba (CA)
Corresponding author
Davie, James R.
Venue
The Journal of Nutrition
Publisher
Elsevier BV
Published
2003-07
Volume
133
Issue
7
Pages
2485S-2493S
ISSN
0022-3166 (ISSN-L)
OpenAlex
W2140937256
Cited by
1,515
References
91
Citations by year
2026: 132 · 2025: 124 · 2024: 89 · 2023: 92 · 2022: 104 · 2021: 96 · 2020: 74 · 2019: 76 · 2018: 79 · 2017: 73 · 2016: 79 · 2015: 65 · 2014: 69 · 2013: 63 · 2012: 53
FWCI
1.85
Type
journal article
Language
en
Open access
Locations
  • Journal of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
butyrate, histone deacetylase inhibition, histone hyperacetylation, Sp1, Sp3, HDAC1, HDAC2, CK2 phosphorylation, p21, CDK2, cell cycle arrest, cell differentiation, gene expression regulation, chromatin structure, histone deacetylase inhibitors, cancer prevention
MeSH terms
Acetyltransferases, Breast Neoplasms, Butyrates, Enzyme Inhibitors, Female, Gene Expression Regulation, Histone Deacetylases, Humans, Tumor Cells, Cultured, Saccharomyces cerevisiae Proteins, Histone Acetyltransferases, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review